AAAAAA

   
Results: 1-13 |
Results: 13
L-dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations
Authors: Pearce, RKB Heikkila, M Linden, IB Jenner, P
Citation: Rkb. Pearce et al., L-dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations, PSYCHOPHAR, 156(4), 2001, pp. 402-409
GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed commonmarmosets
Authors: Iravani, MM Costa, S Jackson, MJ Tel, BC Cannizzaro, C Pearce, RKB Jenner, P
Citation: Mm. Iravani et al., GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed commonmarmosets, EUR J NEURO, 13(3), 2001, pp. 597-608
Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)
Authors: Maratos, EC Jackson, MJ Pearce, RKB Jenner, P
Citation: Ec. Maratos et al., Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus), MOVEMENT D, 16(4), 2001, pp. 631-641
Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study
Authors: Zeng, BY Pearce, RKB MacKenzie, GM Jenner, P
Citation: By. Zeng et al., Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study, J NEURAL TR, 108(8-9), 2001, pp. 925-941
Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets
Authors: Costa, S Iravani, MM Pearce, RKB Jenner, P
Citation: S. Costa et al., Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets, EUR J PHARM, 412(1), 2001, pp. 45-50
Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA
Authors: Zeng, BY Pearce, RKB MacKenzie, GM Jenner, P
Citation: By. Zeng et al., Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA, EUR J NEURO, 12(3), 2000, pp. 1096-1104
Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset
Authors: Smith, LA Jackson, MG Bonhomme, C Chezaubernard, C Pearce, RKB Jenner, P
Citation: La. Smith et al., Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset, CLIN NEUROP, 23(3), 2000, pp. 133-142
Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or withselective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys
Authors: Kanda, T Jackson, MJ Smith, LA Pearce, RKB Nakamura, J Kase, H Kuwana, Y Jenner, P
Citation: T. Kanda et al., Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or withselective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys, EXP NEUROL, 162(2), 2000, pp. 321-327
Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset
Authors: Jenner, P Zeng, BY Smith, LA Pearce, RKB Tel, B Chancharme, L Moachon, G
Citation: P. Jenner et al., Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset, EXP BRAIN R, 133(2), 2000, pp. 178-188
Actions of the D-1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets
Authors: Pearce, RKB Jackson, M Britton, DR Shiosaki, K Jenner, P Marsden, CD
Citation: Rkb. Pearce et al., Actions of the D-1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets, PSYCHOPHAR, 142(1), 1999, pp. 51-60
L-dopa and dyskinesias in normal monkeys
Authors: Pearce, RKB
Citation: Rkb. Pearce, L-dopa and dyskinesias in normal monkeys, MOVEMENT D, 14, 1999, pp. 9-12
Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration
Authors: Litvan, I Grimes, DA Lang, AE Jankovic, J McKee, A Verny, M Jellinger, K Chaudhuri, KR Pearce, RKB
Citation: I. Litvan et al., Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration, J NEUROL, 246, 1999, pp. 1-5
Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosets
Authors: Pearce, RKB Costa, S Jenner, P Marsden, CD
Citation: Rkb. Pearce et al., Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosets, J NEURAL TR, 106(7-8), 1999, pp. 663-683
Risultati: 1-13 |